Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth
I Campbell1, A Magliocco, T Moyana
1Department of Microbiology, Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, Canada.
Abstract:
The p16INK4 tumor suppressor gene encodes a protein that inhibits cyclin-dependent kinase 4, and its homologous deletion is common in human breast cancer. p16INK4 gene transfer has been reported to be efficacious in inducing growth inhibition of various human tumors such as brain, lung, prostate, and esophageal cancers. However, the efficiency of the p16INK4 gene with regard to growth inhibition of human breast cancer has not been studied extensively. To examine its tumor-suppressive function and its potential in breast cancer gene therapy, the wild-type p16INK4 gene was expressed in an adenovirus-mediated gene delivery system and introduced into breast cancer cell lines that do not express p16INK4 protein. Expression of the introduced p16INK4 blocked tumor cell entry into the S phase of the cell cycle, induced tumor cell apoptosis, and inhibited tumor cell proliferation both in vitro and in vivo. These results strongly suggest that p16INK4 is a tumor suppressor gene and suggest that it has potential utility in breast cancer gene therapy.
Insights
The p16INK4 tumor suppressor gene effectively inhibits breast cancer cell growth by blocking cell cycle progression and inducing apoptosis. This study highlights its potential for breast cancer gene therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The p16INK4 tumor suppressor gene inhibits cyclin-dependent kinase 4.
- Homologous deletion of p16INK4 is frequent in human breast cancer.
- Previous studies show p16INK4 gene transfer inhibits various human tumors.
Purpose of the Study:
- To investigate the tumor-suppressive function of p16INK4 in human breast cancer.
- To evaluate the efficacy of p16INK4 gene transfer for breast cancer therapy.
- To examine the role of p16INK4 in breast cancer cell cycle regulation and apoptosis.
Main Methods:
- Adenovirus-mediated gene delivery system used to introduce wild-type p16INK4 gene.
- Expression of p16INK4 in breast cancer cell lines lacking endogenous p16INK4 protein.
- In vitro and in vivo assays to assess tumor cell proliferation, cell cycle, and apoptosis.
Main Results:
- Introduced p16INK4 expression blocked tumor cell entry into S phase of the cell cycle.
- p16INK4 gene transfer induced tumor cell apoptosis.
- Significant inhibition of tumor cell proliferation observed both in vitro and in vivo.
Conclusions:
- p16INK4 functions as a potent tumor suppressor gene in breast cancer.
- p16INK4 gene therapy demonstrates significant potential for treating human breast cancer.
- Further research into p16INK4-based therapeutic strategies for breast cancer is warranted.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...


